ReachMD

Be part of the knowledge.™

Global Oncology Academy

The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.

For more information about GOA, visit www.globaloncologyacademy.org.

802

LikeLikedUnlike

Episodes 1-15 of 106

0
Minute CME/CE
HER2-Directed ADCs in Gastric Cancer
HER2-Directed ADCs in Gastric Cancer
1.00 program credits
0
Minute CME/CE
HER3-Directed ADCs in Breast Cancer
HER3-Directed ADCs in Breast Cancer
1.00 program credits
- Jacob D. Soumerai, MD
  Peer
- Andrew H. Lipsky, MD
  Peer
1
CME/CE
Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
0.25 credits
- Susan O’Brien, MD
  Peer
- Timothy Call, MD
  Peer
1
CME/CE
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
0.25 credits
0
Minute CME/CE
HER3-Directed ADCs in Lung Cancer
HER3-Directed ADCs in Lung Cancer
1.00 program credits
0
Minute CME/CE
HER2-Directed ADCs in Lung Cancer
HER2-Directed ADCs in Lung Cancer
1.00 program credits
- Ian W. Flinn, MD, PhD
  Peer
- William Wierda, MD
  Peer
1
CME/CE
Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling: A Multispecialty Approach
Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling: A Multispecialty Approach
0.25 credits
0
Minute CME/CE
TROP2-Directed ADCs in Lung Cancer
TROP2-Directed ADCs in Lung Cancer
1.00 program credits
1
Minute CME/CE
HER2-Directed ADCs in Breast Cancer
HER2-Directed ADCs in Breast Cancer
1.00 program credits
0
Minute CME/CE
Nectin-4-Directed ADCs in Bladder Cancer
Nectin-4-Directed ADCs in Bladder Cancer
1.00 program credits
0
Minute CME/CE
TROP2-Directed ADCs in Bladder Cancer
TROP2-Directed ADCs in Bladder Cancer
1.00 program credits
0
Minute CME/CE
TROP2-Directed ADCs in Breast Cancer
TROP2-Directed ADCs in Breast Cancer
1.00 program credits
- Luis Paz-Ares, MD, PhD
  Peer
- Kristen Marrone, MD
  Peer
3
CME/CE
Empowering Clinicians to Optimize Patient Outcomes: Addressing Global Challenges in the Use of Immunotherapy in NSCLC
Empowering Clinicians to Optimize Patient Outcomes: Addressing Global Challenges in the Use of Immunotherapy in NSCLC
0.50 credits
- Pavani Chalasani MD, MPH
  Peer
- Kevin Kalinsky MD, MS
  Peer
0
Project Oncology®
Conversations Around Chemotherapy: Do All of Your Patients Need It?
Conversations Around Chemotherapy: Do All of Your Patients Need It?
- Lyudmila Bazhenova, MD
  Peer
- Benjamin Levy, MD
  Peer
6
CME/CE
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
0.25 credits

Segment Chapters

Playlist:

Recommended

Webpack App